These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 27523610

  • 1. Electroanatomic Properties of the Myocardium Predict Response to CD34+ Cell Therapy in Patients With Ischemic and Nonischemic Heart Failure.
    Zemljic G, Poglajen G, Sever M, Cukjati M, Frljak S, Androcec V, Cernelc P, Haddad F, Vrtovec B.
    J Card Fail; 2017 Feb; 23(2):153-160. PubMed ID: 27523610
    [Abstract] [Full Text] [Related]

  • 2. Effects of intracoronary CD34+ stem cell transplantation in nonischemic dilated cardiomyopathy patients: 5-year follow-up.
    Vrtovec B, Poglajen G, Lezaic L, Sever M, Domanovic D, Cernelc P, Socan A, Schrepfer S, Torre-Amione G, Haddad F, Wu JC.
    Circ Res; 2013 Jan 04; 112(1):165-73. PubMed ID: 23065358
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effects of transendocardial CD34+ cell transplantation in patients with ischemic cardiomyopathy.
    Poglajen G, Sever M, Cukjati M, Cernelc P, Knezevic I, Zemljic G, Haddad F, Wu JC, Vrtovec B.
    Circ Cardiovasc Interv; 2014 Aug 04; 7(4):552-9. PubMed ID: 25097199
    [Abstract] [Full Text] [Related]

  • 5. Efficacy of CD34+ Stem Cell Therapy in Nonischemic Dilated Cardiomyopathy Is Absent in Patients With Diabetes but Preserved in Patients With Insulin Resistance.
    Vrtovec B, Sever M, Jensterle M, Poglajen G, Janez A, Kravos N, Zemljic G, Cukjati M, Cernelc P, Haddad F, Wu JC, Jorde UP.
    Stem Cells Transl Med; 2016 May 04; 5(5):632-8. PubMed ID: 27025690
    [Abstract] [Full Text] [Related]

  • 6. Favorable Response to CD34+ Cell Therapy Is Associated with a Decrease of Galectin-3 Levels in Patients with Chronic Heart Failure.
    Poglajen G, Ksela J, Frljak S, Zemljic G, Boznar Alic E, Cerar A, Vrtovec B.
    Dis Markers; 2019 May 04; 2019():8636930. PubMed ID: 31885743
    [Abstract] [Full Text] [Related]

  • 7. Comparison of transendocardial and intracoronary CD34+ cell transplantation in patients with nonischemic dilated cardiomyopathy.
    Vrtovec B, Poglajen G, Lezaic L, Sever M, Socan A, Domanovic D, Cernelc P, Torre-Amione G, Haddad F, Wu JC.
    Circulation; 2013 Sep 10; 128(11 Suppl 1):S42-9. PubMed ID: 24030420
    [Abstract] [Full Text] [Related]

  • 8. Differential outcome of cardiac resynchronization therapy in ischemic cardiomyopathy and idiopathic dilated cardiomyopathy.
    McLeod CJ, Shen WK, Rea RF, Friedman PA, Hayes DL, Wokhlu A, Webster TL, Wiste HJ, Hodge DO, Bradley DJ, Hammill SC, Packer DL, Cha YM.
    Heart Rhythm; 2011 Mar 10; 8(3):377-82. PubMed ID: 21070886
    [Abstract] [Full Text] [Related]

  • 9. Effects of surgical ventricular reconstruction and mitral complex reconstruction on cardiac oxidative metabolism and efficiency in nonischemic and ischemic dilated cardiomyopathy.
    Sugiki T, Naya M, Manabe O, Wakasa S, Kubota S, Chiba S, Iwano H, Yamada S, Yoshinaga K, Tamaki N, Tsutsui H, Matsui Y.
    JACC Cardiovasc Imaging; 2011 Jul 10; 4(7):762-70. PubMed ID: 21757167
    [Abstract] [Full Text] [Related]

  • 10. Immunologic Network and Response to Intramyocardial CD34+ Stem Cell Therapy in Patients With Dilated Cardiomyopathy.
    Haddad F, Sever M, Poglajen G, Lezaic L, Yang P, Maecker H, Davis M, Kuznetsova T, Wu JC, Vrtovec B.
    J Card Fail; 2015 Jul 10; 21(7):572-82. PubMed ID: 25863169
    [Abstract] [Full Text] [Related]

  • 11. Comparison of Mesenchymal Stem Cell Efficacy in Ischemic Versus Nonischemic Dilated Cardiomyopathy.
    Tompkins BA, Rieger AC, Florea V, Banerjee MN, Natsumeda M, Nigh ED, Landin AM, Rodriguez GM, Hatzistergos KE, Schulman IH, Hare JM.
    J Am Heart Assoc; 2018 Jul 12; 7(14):. PubMed ID: 30005555
    [Abstract] [Full Text] [Related]

  • 12. Effects of Repetitive Transendocardial CD34+ Cell Transplantation in Patients With Nonischemic Dilated Cardiomyopathy.
    Vrtovec B, Poglajen G, Sever M, Zemljic G, Frljak S, Cerar A, Cukjati M, Jaklic M, Cernelc P, Haddad F, Wu JC.
    Circ Res; 2018 Jul 20; 123(3):389-396. PubMed ID: 29880546
    [Abstract] [Full Text] [Related]

  • 13. Intracoronary transplantation of CD34(+) cells is associated with improved myocardial perfusion in patients with nonischemic dilated cardiomyopathy.
    Lezaic L, Socan A, Poglajen G, Peitl PK, Sever M, Cukjati M, Cernelc P, Wu JC, Haddad F, Vrtovec B.
    J Card Fail; 2015 Feb 20; 21(2):145-52. PubMed ID: 25459687
    [Abstract] [Full Text] [Related]

  • 14. The presence of electromechanical mismatch in nonischemic dilated cardiomyopathy is associated with ventricular repolarization instability.
    Mikuz U, Poglajen G, Fister M, Starc V, Wu JC, Hsia H, Haddad F, Vrtovec B.
    J Card Fail; 2014 Dec 20; 20(12):891-8. PubMed ID: 25305502
    [Abstract] [Full Text] [Related]

  • 15. Changes in ventricular remodelling and clinical status during the year following a single administration of stromal cell-derived factor-1 non-viral gene therapy in chronic ischaemic heart failure patients: the STOP-HF randomized Phase II trial.
    Chung ES, Miller L, Patel AN, Anderson RD, Mendelsohn FO, Traverse J, Silver KH, Shin J, Ewald G, Farr MJ, Anwaruddin S, Plat F, Fisher SJ, AuWerter AT, Pastore JM, Aras R, Penn MS.
    Eur Heart J; 2015 Sep 01; 36(33):2228-38. PubMed ID: 26056125
    [Abstract] [Full Text] [Related]

  • 16. Effects of Transendocardial CD34+ Cell Transplantation on Diastolic Parameters in Patients with Nonischemic Dilated Cardiomyopathy.
    Bervar M, Kozelj M, Poglajen G, Sever M, Zemljic G, Frljak S, Cukjati M, Cernelc P, Haddad F, Vrtovec B.
    Stem Cells Transl Med; 2017 Jun 01; 6(6):1515-1521. PubMed ID: 28296283
    [Abstract] [Full Text] [Related]

  • 17. A pilot trial to assess potential effects of selective intracoronary bone marrow-derived progenitor cell infusion in patients with nonischemic dilated cardiomyopathy: final 1-year results of the transplantation of progenitor cells and functional regeneration enhancement pilot trial in patients with nonischemic dilated cardiomyopathy.
    Fischer-Rasokat U, Assmus B, Seeger FH, Honold J, Leistner D, Fichtlscherer S, Schächinger V, Tonn T, Martin H, Dimmeler S, Zeiher AM.
    Circ Heart Fail; 2009 Sep 01; 2(5):417-23. PubMed ID: 19808371
    [Abstract] [Full Text] [Related]

  • 18. Clinical characteristics and long-term prognosis in patients with chronic heart failure and reduced ejection fraction in China.
    Liu X, Yu H, Pei J, Chu J, Pu J, Zhang S.
    Heart Lung Circ; 2014 Sep 01; 23(9):818-26. PubMed ID: 24881031
    [Abstract] [Full Text] [Related]

  • 19. Regional heterogeneity of decreased myocardial norepinephrine and increased lipid peroxidation levels in patients with end-stage failing heart secondary to dilated or ischemic cardiomyopathy.
    Rochette L, Tatou E, Vergely C, Maupoil V, Bouchot O, Mossiat C, Jazayeri S, Benkhadra S, Brenot R, Girard C, David M.
    J Heart Lung Transplant; 2008 Jul 01; 27(7):767-74. PubMed ID: 18582807
    [Abstract] [Full Text] [Related]

  • 20. Right ventricular myocardial function in patients with either idiopathic or ischemic dilated cardiomyopathy without clinical sign of right heart failure: effects of cardiac resynchronization therapy.
    D'Andrea A, Salerno G, Scarafile R, Riegler L, Gravino R, Castaldo F, Cocchia R, Limongelli G, Romano M, Calabrò P, Nigro G, Cuomo S, Bossone E, Caso P, Calabrò R.
    Pacing Clin Electrophysiol; 2009 Aug 01; 32(8):1017-29. PubMed ID: 19659622
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.